RBx-14255

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameRBx-14255
Drug Alias NameRBx-10014255
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsPneumonia, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRanbaxy Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRanbaxy Laboratories Ltd
Active IndicationsN/A
Inactive IndicationsPneumonia, Bacterial

Other Information

ATC CodeN/A
Related LinksN/A